ArticleThe patient2009
Patient preferences for an oral anticoagulant after major orthopedic surgery: results of a german survey.
Article in The patient, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: a meta-analysis of randomized controlled trials.Journal of orthopaedic surgery and research · 2024Pooled it
- Safety and Efficacy of New Anticoagulants for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty: A Meta-Analysis.The Journal of arthroplasty · 2017Pooled it
- Incorporating Patient Preferences into a Decision-Making Model of Hand Trauma Reconstruction.International journal of environmental research and public health · 2021Article
- Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021Article
- Shared Decision Making: From Decision Science to Data Science.Medical decision making : an international journal of the Society for Medical Decision Making · 2020Article
- Extended thromboprophylaxis for hip or knee arthroplasty. Does the administration route and dosage regimen affect adherence? A cohort study.International orthopaedics · 2020Article
- Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry.Clinical orthopaedics and related research · 2019Article
- Aspirin: are patients actually taking it?-A quality assessment study.Arthroplasty today · 2018Article
- Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.Vascular health and risk management · 2018Observational
- The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery.SpringerPlus · 2016Article
- Patients' perception about risks and benefits of antithrombotic treatment for the prevention of venous thromboembolism (VTE) after orthopedic surgery: a qualitative study.BMC musculoskeletal disorders · 2015Article
- Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran.Vascular health and risk management · 2015Review
- Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.Therapeutic advances in neurological disorders · 2014Article
- [Patient pathways in thrombosis prophylaxis after hip and knee replacement surgery : results of a survey].Der Orthopade · 2011Article
- Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery.Clinical orthopaedics and related research · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSince 2008, the availability of the oral direct thrombin inhibitor dabigatran etexilate provides a further therapeutic alternative to injectable low-molecular-weight heparin (LMWH) for thromboprophylaxis following hip or knee replacement surgery. The intention of this study is to analyze patient preferences for this new oral thromboprophylaxis agent.
methodsFace-to-face interviews were conducted with 73 doctors and nurses in 12 German hospitals, 195 current hip and knee replacement patients in six German rehabilitation hospitals, and 202 former thromboprophylaxis patients. Qualitative questions were complemented by a full-profile ranking-based conjoint analysis regarding alternative thromboprophylaxis regimens.
resultsNearly 100% of the interviewed medical staff viewed the daily subcutaneous LMWH injection as a source of inconvenience for patients. However, both current and former patients perceived their discomfort to be much less intense. In contrast, the conjoint estimates of preferences showed that older and male patients in particular understated their levels of discomfort in a face-to-face interview situation and had a strong preference for oral anticoagulation.
conclusionsPatients in Germany appear to have a positive preference for oral thromboprophylaxis after major orthopedic surgery.
Identifiers
22273058What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.